相关实验视频

Updated: May 5, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

通过干扰素调节因子5重编程损伤性巨细胞平衡,针对动脉样硬化治疗的向siRNA纳米免疫治疗

Zhongshan He^1,2, Yaoyao Luo³, Shuping Yang¹

¹Department of Clinical Pharmacy, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Tianfu Jincheng Laboratory, Chengdu 610041, China.

|March 4, 2026

概括

研究人员开发了一种新的双重向纳米疗法,使用小干扰RNA (siIRF5) 来重新编程促炎性巨细胞. 这种方法有效地减少了动脉样硬化进展,并增强了小鼠的斑块稳定性,显示出治疗炎症疾病的希望.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
心血管研究研究心血管研究

背景情况:

动脉样硬化中的巨细胞采用一种亲炎性表型,加速疾病的进展.
干扰素调节因子5 (IRF5) 在损伤性巨细胞中被上调,促进炎症.
现有的疗法缺乏有针对性的方法来调节斑块巨细胞中的IRF5.

研究的目的:

开发和评估一种双重向的,基于siRNA的用于动脉样硬化的纳米治疗平台.
在受损巨细胞中选择性地沉默IRF5,并重新编程它们的表型.
在临床前模型中评估这种纳米免疫疗法的治疗疗效和安全性.

主要方法:

设计和合成的双向脂质体封装siRNA与IRF5 (siIRF5) 的设计和合成.
向高脂肪饮食养的具有先进动脉样硬化斑块的ApoE-/-小鼠注射siIRF5装载脂质体.
评估纳米粒子积累,IRF5下调,巨细胞极化,斑块负担和斑块稳定性.

主要成果:

双重向的siIRF5脂质体有效地积聚在损伤性巨细胞中.
IRF5表达被降低了,导致向抗炎性巨细胞两极分化转变.
观察到动脉样硬化斑块负担显著降低,斑块稳定性得到改善.
纳米免疫疗法在长期使用时显示出良好的生物相容性.

结论:

一个双向的siRNA纳米治疗平台有效地重编程动脉样硬化中的损伤性巨细胞.
该策略通过针对IRF5.5来为动脉样硬化提供了一个有前途的治疗方法.
开发的纳米免疫疗法具有治疗动脉样硬化和其他巨驱动的炎症性疾病的翻译潜力.

关键词:

动脉样硬化动脉样硬化巨细胞的恒常性.纳米免疫疗法是一种纳米免疫疗法.小小的干扰RNA可以干扰RNA.有针对性的交付目标.

更多相关视频

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

相关概念视频

Inflammation

Inflammation

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...